High CERT expression is associated with poorer breast cancer outcomes, whereas low CERT expression is correlated to better chemotherapeutic outcomes in a cohort of Leeds Teaching Hospitals, UK [155]. The gene discussed is CERT1; the disease is breast carcinoma.